MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09273948.2026.2690412

Медицинская библиотека · Ocular immunology and inflammation · 2026

Upadacitinib in Refractory Vogt-Koyanagi-Harada Disease: A Case Report.

Rajpurohit Tapasya, Kaushik Madhulika, Kaushik Viswanath V, Biswas Jyotirmay

Клинический случайСтатьяПеревод в очереди

Аннотация

PURPOSE: To evaluate the role of Upadacitinib, a selective Janus kinase-1 (JAK-1) inhibitor, in the management of refractory Vogt-Koyanagi-Harada (VKH) disease.

METHODS

A 25-year-old male was diagnosed with bilateral VKH disease based on clinical findings and supportive investigations. He experienced multiple recurrences despite treatment with conventional therapies, including systemic corticosteroids, cyclosporine, mycophenolate mofetil (MMF), and adalimumab. The patient also demonstrated intolerance to systemic steroids. He was subsequently classified as having refractory VKH in both eyes and was initiated on oral Upadacitinib.

RESULTS

Following the initiation of oral Upadacitinib, a novel selective JAK-1 inhibitor, there was complete resolution of subretinal fluid (SRF), with no further recurrences observed during follow-up, resulting in sustained disease stability.

CONCLUSION

This case underscores the potential utility of selective JAK-1 inhibition in the management of refractory VKH disease, particularly in patients who are unresponsive to or intolerant of conventional corticosteroid and immunosuppressive therapies.

Для цитирования: Rajpurohit Tapasya, Kaushik Madhulika, Kaushik Viswanath V, Biswas Jyotirmay. Upadacitinib in Refractory Vogt-Koyanagi-Harada Disease: A Case Report.. Ocular immunology and inflammation. 2026. DOI: 10.1080/09273948.2026.2690412.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.